JP2022538789A5 - - Google Patents
Info
- Publication number
- JP2022538789A5 JP2022538789A5 JP2021573843A JP2021573843A JP2022538789A5 JP 2022538789 A5 JP2022538789 A5 JP 2022538789A5 JP 2021573843 A JP2021573843 A JP 2021573843A JP 2021573843 A JP2021573843 A JP 2021573843A JP 2022538789 A5 JP2022538789 A5 JP 2022538789A5
- Authority
- JP
- Japan
- Prior art keywords
- crispr
- nucleic acid
- related protein
- target nucleic
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962861582P | 2019-06-14 | 2019-06-14 | |
| US62/861,582 | 2019-06-14 | ||
| US201962872157P | 2019-07-09 | 2019-07-09 | |
| US62/872,157 | 2019-07-09 | ||
| US201962873602P | 2019-07-12 | 2019-07-12 | |
| US201962873606P | 2019-07-12 | 2019-07-12 | |
| US62/873,602 | 2019-07-12 | ||
| US62/873,606 | 2019-07-12 | ||
| PCT/US2020/037585 WO2020252378A1 (en) | 2019-06-14 | 2020-06-12 | Novel crispr dna targeting enzymes and systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022538789A JP2022538789A (ja) | 2022-09-06 |
| JP2022538789A5 true JP2022538789A5 (https=) | 2023-06-19 |
Family
ID=73781310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573843A Pending JP2022538789A (ja) | 2019-06-14 | 2020-06-12 | 新規ｃｒｉｓｐｒ ｄｎａターゲティング酵素及びシステム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220315913A1 (https=) |
| EP (1) | EP3983536A4 (https=) |
| JP (1) | JP2022538789A (https=) |
| CN (1) | CN114269912A (https=) |
| AU (1) | AU2020291467A1 (https=) |
| CA (1) | CA3142019A1 (https=) |
| WO (1) | WO2020252378A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4025588A4 (en) * | 2019-09-05 | 2023-09-06 | Arbor Biotechnologies, Inc. | NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS |
| WO2022159741A1 (en) * | 2021-01-22 | 2022-07-28 | Arbor Biotechnologies, Inc. | Compositions comprising a nuclease and uses thereof |
| EP4347818A2 (en) | 2021-06-01 | 2024-04-10 | Arbor Biotechnologies, Inc. | Gene editing systems comprising a crispr nuclease and uses thereof |
| KR20250151430A (ko) | 2023-02-15 | 2025-10-21 | 아버 바이오테크놀로지스, 인크. | 스타스민 2(stmn2) 전사체에서 비정상적인 스플라이싱을 억제하는 유전자 편집 방법 |
| WO2025171210A1 (en) | 2024-02-09 | 2025-08-14 | Arbor Biotechnologies, Inc. | Compositions and methods for gene editing via homology-mediated end joining |
| WO2025201481A1 (en) * | 2024-03-29 | 2025-10-02 | Yoltech Therapeutics Co., Ltd | Crispr-cas systems |
| WO2026015832A2 (en) | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Reverse transcriptases and gene editing systems comprising such |
| WO2026015829A2 (en) | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Small reverse transcriptases and gene editing systems comprising such |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9074199B1 (en) * | 2013-11-19 | 2015-07-07 | President And Fellows Of Harvard College | Mutant Cas9 proteins |
| WO2017044776A1 (en) * | 2015-09-10 | 2017-03-16 | Texas Tech University System | Single-guide rna (sgrna) with improved knockout efficiency |
| AU2017280353B2 (en) * | 2016-06-24 | 2021-11-11 | Inscripta, Inc. | Methods for generating barcoded combinatorial libraries |
| EP3562942A4 (en) * | 2016-12-28 | 2020-12-09 | Ionis Pharmaceuticals, Inc. | MODIFIED CRISPR-RNA AND ITS USES |
| US9982279B1 (en) * | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| WO2019051419A1 (en) * | 2017-09-08 | 2019-03-14 | University Of North Texas Health Science Center | Engineered cas9 variants |
| WO2019090175A1 (en) * | 2017-11-02 | 2019-05-09 | Arbor Biotechnologies, Inc. | Novel crispr-associated transposon systems and components |
-
2020
- 2020-06-12 CN CN202080050922.7A patent/CN114269912A/zh active Pending
- 2020-06-12 EP EP20821952.7A patent/EP3983536A4/en not_active Withdrawn
- 2020-06-12 US US17/619,165 patent/US20220315913A1/en not_active Abandoned
- 2020-06-12 AU AU2020291467A patent/AU2020291467A1/en not_active Abandoned
- 2020-06-12 JP JP2021573843A patent/JP2022538789A/ja active Pending
- 2020-06-12 CA CA3142019A patent/CA3142019A1/en active Pending
- 2020-06-12 WO PCT/US2020/037585 patent/WO2020252378A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022538789A5 (https=) | ||
| US11459588B2 (en) | Methods of use of CRISPR CPF1 hybrid DNA/RNA polynucleotides | |
| JP2022540153A5 (https=) | ||
| JP2022547524A5 (https=) | ||
| JP2025161809A5 (https=) | ||
| JP2022546594A5 (https=) | ||
| CN111836894B (zh) | 用于使用CRISPR/Cpf1系统进行基因组编辑的组合物及其用途 | |
| JP2022546701A5 (https=) | ||
| JP7068821B2 (ja) | 化学修飾を有するガイドｒｎａ | |
| WO2019232069A1 (en) | Cell therapy | |
| FI3802807T3 (fi) | Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi | |
| FI4118198T3 (fi) | Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja käyttömenetelmiä | |
| FI3765615T3 (fi) | Uusia DNA:han kohdentuvia CRISPR-entsyymejä ja järjestelmiä | |
| JP2024524514A5 (https=) | ||
| CA3163087A1 (en) | System and method for activating gene expression | |
| WO2024131940A1 (zh) | 融合物及其用途 | |
| US20200224194A1 (en) | Expression systems that facilitate nucleic acid delivery and methods of use | |
| US20240279687A1 (en) | Peptide nucleic acids for spatiotemporal control of crispr-cas binding | |
| WO2025199534A1 (en) | New r2 retrotransposons for gene writing | |
| HK40102346A (en) | Crispr hybrid dna/rna polynucleotides and methods of use | |
| JP2025535776A (ja) | 遺伝子を標的化、編集又は修飾するための組成物及び方法 | |
| HK1245839B (en) | Crispr hybrid dna/rna polynucleotides and methods of use |